Ingram Douglas S
SEC-identified person · CIK 1190644 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Relay Therapeutics, Inc. RLAY | Director | filed 2020 - 2026 |
| Arrowhead Research Corp ARWR | Director | filed 2025 - 2025 |
| Sarepta Therapeutics, Inc. SRPT | Director · President & CEO | filed 2017 - 2025 |
| Endo International plc ENDP | Director | filed 2016 - 2017 |
| Skye Bioscience, Inc. SKYE | Director · Vice Chairman | filed 2015 - 2015 |
| Allergan INC AGN | President | filed 2006 - 2015 |
| Volcom Inc VLCM | Director | filed 2006 - 2011 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.